POET Technologies: The Photonics Transition Is Getting Real, One Order at a Time
Published on 08/14/2026 at 15:22 | Redaktion boerse-global.de
There is a quiet persistence to POET Technologies' latest numbers that stands in contrast to the noise surrounding the stock. The semiconductor specialist posted second-quarter 2026 results on Thursday that show a company methodically executing its shift from development-stage player to production-ready supplier — even as the share price continues to swing with the volatility of a sector that still trades heavily on promise.
Revenue climbed 112 percent year-over-year to $569,925, marking the sixth consecutive quarter of sequential growth. The net loss narrowed to $11.3 million, or $0.07 per share, improving from $17.3 million in the same period last year. Research and development expenses rose to $5.8 million from $3.1 million, a cost increase management explicitly ties to the transition toward manufacturing.
The Lumilens Framework: A $500 Million Ceiling
The quarter's centerpiece, however, extends well beyond the income statement. A supply and development agreement with Lumilens, signed in May, carries an initial purchase order of $50 million for optical interposer-based engines. POET says the master framework could expand to cumulative orders exceeding $500 million over five years. First engineering samples from the program are expected in late 2026, with production scaling tied to customer deliveries beginning in 2027.
The company added further momentum after the quarter closed: a $2.4 million order from an existing customer and a development agreement with an unnamed Tier-1 laser manufacturer for an external light source engine. POET also indicated it will begin shipping substantial quantities of production units for qualification in the remaining quarters of 2026, with updates slated for September.
Should investors sell immediately? Or is it worth buying POET Technologies?
A Balance Sheet Built for the Long Haul
The financial foundation has shifted dramatically thanks to a registered direct offering completed in May that raised approximately $400 million. Cash and short-term investments stood at $796.3 million at the end of the second quarter, giving the company ample runway to scale manufacturing without near-term capital raises. The real question, as management sees it, is how quickly that cushion converts into repeatable volume orders.
Governance changes have accompanied the operational push. In early August, Dr. Bardia Pezeshki and Jean F. Rankin joined the board of directors, while longtime director Jean-Louis Malinge resigned for personal reasons. Pezeshki brings deep optical communications experience from founding roles at Avicena Tech, Kaiam, and Santur; Rankin adds governance expertise from stints at InterDigital, Resonant, LSI, and Agere. The board also approved the issuance of roughly 2.45 million restricted stock units to senior executives, vesting in equal tranches over three years based on the August 10 closing price of $8.56. Notably, the company has opted against relocating its corporate seat to the United States, maintaining its Canadian roots for now.
Market Skepticism Persists
Not everyone is convinced. Night Market Research published a short position against POET in early August, questioning the status of the Celestial AI partnership and arguing the company has overstated its collaborations. That critique sits uneasily against the recent operational progress, and the debate over valuation shows no signs of cooling.
The chart tells a story of its own. The stock closed Thursday at €7.69, then gained 4.8 percent on Friday to €8.06. Over the past 30 days, the shares are up 11 percent, and they have advanced 40 percent since the start of the year — though they remain 59 percent below the May peak of €18.84. The 12-month gain stands at 76 percent. The shares trade just below the 50-day moving average of €8.12 but comfortably above the 200-day average of €6.91. With an annualized 30-day volatility of 104 percent, this remains one of the most volatile names in the sector.
The next test arrives with the third-quarter report on November 12, when investors will see whether the Lumilens order flow has begun showing up in revenue. Analysts currently expect a loss of $0.07 per share for the period. Whether the promised production shipments gain real traction will determine if this photonics bet is gradually becoming a durable business model — or remains a story of potential waiting for its payoff.
Ad
POET Technologies Stock: New Analysis - 14 August
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
